2021 专家共识：阿片类药物使用障碍者晚期癌症相关疼痛的管理

2021-12-01 国外肿瘤科相关专家小组（统称） JAMA Netw Open

阿片类药物使用障碍（OUD）是晚期癌症患者的一种重要共病，其疼痛常见。本文主要针对晚期癌症和OUD患者癌症疼痛的管理提供共识指导。

中文标题：

发布机构：

国外肿瘤科相关专家小组（统称）

发布日期：

2021-12-01

简要介绍：

阿片类药物使用障碍（OUD）是晚期癌症患者的一种重要共病，其疼痛常见。本文主要针对晚期癌症和OUD患者癌症疼痛的管理提供共识指导。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=ac41c1c002306e5f, title=2021 专家共识：阿片类药物使用障碍者晚期癌症相关疼痛的管理, enTitle=, guiderFrom=JAMA Netw Open, authorId=0, author=, summary=阿片类药物使用障碍（OUD）是晚期癌症患者的一种重要共病，其疼痛常见。本文主要针对晚期癌症和OUD患者癌症疼痛的管理提供共识指导。, cover=https://img.medsci.cn/20211229/1640742975063_5579292.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Wed Dec 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">阿片类药物使用障碍（OUD）是晚期癌症患者的一种重要共病，其疼痛常见。本文主要针对晚期癌症和OUD患者癌症疼痛的管理提供共识指导。</span></p>, tagList=[TagDto(tagId=24020, tagName=疼痛管理), TagDto(tagId=87203, tagName=阿片类药物使用障碍), TagDto(tagId=97940, tagName=癌症疼痛管理)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=29, categoryName=麻醉疼痛, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=87203, guiderKeyword=阿片类药物使用障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8505, appHits=113, showAppHits=0, pcHits=713, showPcHits=8392, likes=1, shares=14, comments=5, approvalStatus=1, publishedTime=Wed Dec 29 09:53:30 CST 2021, publishedTimeString=2021-12-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Dec 29 09:56:29 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 04:59:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 专家共识：阿片类药物使用障碍者晚期癌症相关疼痛的管理.pdf)])

2021 专家共识：阿片类药物使用障碍者晚期癌症相关疼痛的管理.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1182737, encodeId=86091182e3780, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82ed95484, createdName=oooodoctor, createdTime=Mon Jan 10 09:07:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182287, encodeId=0dd4118228e72, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2585076812, createdName=145a4e94m56暂无昵称, createdTime=Sat Jan 08 17:21:09 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178936, encodeId=1b2811e8936c8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ade354b7937d4544a057c9b00b8e078d/d3288fe9f87f4588a2355d39ba9ce170.jpg, createdBy=b7886428247, createdName=不要叫我的名字！, createdTime=Thu Dec 30 18:26:50 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085801, encodeId=7a23108580155, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:57:36 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2022-01-10 oooodoctor

好东西

128 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1182737, encodeId=86091182e3780, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82ed95484, createdName=oooodoctor, createdTime=Mon Jan 10 09:07:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182287, encodeId=0dd4118228e72, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2585076812, createdName=145a4e94m56暂无昵称, createdTime=Sat Jan 08 17:21:09 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178936, encodeId=1b2811e8936c8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ade354b7937d4544a057c9b00b8e078d/d3288fe9f87f4588a2355d39ba9ce170.jpg, createdBy=b7886428247, createdName=不要叫我的名字！, createdTime=Thu Dec 30 18:26:50 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085801, encodeId=7a23108580155, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:57:36 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2022-01-08 145a4e94m56暂无昵称

学习

132 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1182737, encodeId=86091182e3780, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82ed95484, createdName=oooodoctor, createdTime=Mon Jan 10 09:07:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182287, encodeId=0dd4118228e72, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2585076812, createdName=145a4e94m56暂无昵称, createdTime=Sat Jan 08 17:21:09 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178936, encodeId=1b2811e8936c8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ade354b7937d4544a057c9b00b8e078d/d3288fe9f87f4588a2355d39ba9ce170.jpg, createdBy=b7886428247, createdName=不要叫我的名字！, createdTime=Thu Dec 30 18:26:50 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085801, encodeId=7a23108580155, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:57:36 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2021-12-30 不要叫我的名字！

学习学习

136 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1182737, encodeId=86091182e3780, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82ed95484, createdName=oooodoctor, createdTime=Mon Jan 10 09:07:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182287, encodeId=0dd4118228e72, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2585076812, createdName=145a4e94m56暂无昵称, createdTime=Sat Jan 08 17:21:09 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178936, encodeId=1b2811e8936c8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ade354b7937d4544a057c9b00b8e078d/d3288fe9f87f4588a2355d39ba9ce170.jpg, createdBy=b7886428247, createdName=不要叫我的名字！, createdTime=Thu Dec 30 18:26:50 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085801, encodeId=7a23108580155, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:57:36 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2021-12-30 66304_9712

学习学习

127 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤指南

2021 专家共识：阿片类药物使用障碍者晚期癌症相关疼痛的管理

相关指南

拓展阅读

科室

工具

服务